MoneyWorks4Me

AstraZeneca Pharma India informs about unaudited financial results

06 Feb 2018 Evaluate

AstraZeneca Pharma India has informed about the Board Meeting of the Company held on Monday, February 5, 2018, has considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..